For Industry

Enhanced Accountability & Reporting

To promote accountability and transparency, GDUFA II includes provisions so that industry and public stakeholders can observe the Agency’s productivity and performance with generic drug reviews under GDUFA II. The links below provide data on GDUFA metrics and are updated periodically:


Page Last Updated: 01/25/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English